• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022

    12/14/22 10:01:40 AM ET
    $ABCM
    $ACRS
    $ADM
    $AGRO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABCM alert in real time by email

    Upgrades

    Wolfe Research upgraded the previous rating for EQT Corp (NYSE:EQT) from Peer Perform to Outperform. EQT earned $1.04 in the third quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.97 and a 52-week-low of $19.20. EQT closed at $37.11 at the end of the last trading period.

    For Lennar Corp (NYSE:LEN), Barclays upgraded the previous rating of Equal-Weight to Overweight. At the moment, the stock has a 52-week-high of $117.54 and a 52-week-low of $62.54. Lennar closed at $90.59 at the end of the last trading period.

    According to Barclays, the prior rating for PulteGroup Inc (NYSE:PHM) was changed from Equal-Weight to Overweight. For the third quarter, PulteGroup had an EPS of $2.69, compared to year-ago quarter EPS of $1.82. The stock has a 52-week-high of $58.09 and a 52-week-low of $35.03. At the end of the last trading period, PulteGroup closed at $45.79.

    For SolarEdge Technologies Inc (NASDAQ:SEDG), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, SolarEdge Technologies showed an EPS of $0.91, compared to $1.45 from the year-ago quarter. The stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. At the end of the last trading period, SolarEdge Technologies closed at $327.64.

    For RingCentral Inc (NYSE:RNG), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, RingCentral showed an EPS of $0.55, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $198.79 and a 52-week-low of $28.00. RingCentral closed at $38.95 at the end of the last trading period.

    Morgan Stanley upgraded the previous rating for PACCAR Inc (NASDAQ:PCAR) from Equal-Weight to Overweight. In the third quarter, PACCAR showed an EPS of $2.21, compared to $1.08 from the year-ago quarter. The current stock performance of PACCAR shows a 52-week-high of $107.18 and a 52-week-low of $77.00. Moreover, at the end of the last trading period, the closing price was at $102.22.

    For Datadog Inc (NASDAQ:DDOG), Oppenheimer upgraded the previous rating of Perform to Outperform. For the third quarter, Datadog had an EPS of $0.23, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $186.28 and a 52-week-low of $66.45. Datadog closed at $79.71 at the end of the last trading period.

    Wells Fargo upgraded the previous rating for Fortis Inc (NYSE:FTS) from Underweight to Equal-Weight. For the third quarter, Fortis had an EPS of $0.54, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $51.66 and a 52-week-low of $34.76. At the end of the last trading period, Fortis closed at $40.99.

    For Playa Hotels & Resorts NV (NASDAQ:PLYA), Citigroup upgraded the previous rating of Neutral to Buy. In the third quarter, Playa Hotels & Resorts showed an EPS of $0.04, compared to $0.09 from the year-ago quarter. The current stock performance of Playa Hotels & Resorts shows a 52-week-high of $9.81 and a 52-week-low of $5.34. Moreover, at the end of the last trading period, the closing price was at $6.12.

    According to Wedbush, the prior rating for Darden Restaurants Inc (NYSE:DRI) was changed from Neutral to Outperform. In the first quarter, Darden Restaurants showed an EPS of $1.56, compared to $1.76 from the year-ago quarter. The current stock performance of Darden Restaurants shows a 52-week-high of $155.25 and a 52-week-low of $110.96. Moreover, at the end of the last trading period, the closing price was at $145.03.

    For Gentex Corp (NASDAQ:GNTX), Goldman Sachs upgraded the previous rating of Sell to Neutral. Gentex earned $0.31 in the third quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $36.65 and a 52-week-low of $23.28. At the end of the last trading period, Gentex closed at $27.43.

    For Ncino Inc (NASDAQ:NCNO), Baird upgraded the previous rating of Neutral to Outperform. For the third quarter, Ncino had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $58.71 and a 52-week-low of $22.97. At the end of the last trading period, Ncino closed at $26.67.

    Baird upgraded the previous rating for Ansys Inc (NASDAQ:ANSS) from Neutral to Outperform. Ansys earned $1.77 in the third quarter, compared to $1.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $413.22 and a 52-week-low of $194.23. Ansys closed at $254.54 at the end of the last trading period.

    Keybanc upgraded the previous rating for EastGroup Properties Inc (NYSE:EGP) from Sector Weight to Overweight. In the third quarter, EastGroup Props showed an EPS of $1.77, compared to $1.55 from the year-ago quarter. At the moment, the stock has a 52-week-high of $229.84 and a 52-week-low of $137.47. EastGroup Props closed at $156.84 at the end of the last trading period.

    Keybanc upgraded the previous rating for Physicians Realty Trust (NYSE:DOC) from Sector Weight to Overweight. In the third quarter, Physicians Realty Trust showed an EPS of $0.26, compared to $0.26 from the year-ago quarter. The current stock performance of Physicians Realty Trust shows a 52-week-high of $19.12 and a 52-week-low of $13.42. Moreover, at the end of the last trading period, the closing price was at $15.00.

    See all analyst ratings upgrades.

    Downgrades

    According to Chardan Capital, the prior rating for Moderna Inc (NASDAQ:MRNA) was changed from Buy to Neutral. For the third quarter, Moderna had an EPS of $2.53, compared to year-ago quarter EPS of $7.70. The current stock performance of Moderna shows a 52-week-high of $321.31 and a 52-week-low of $115.03. Moreover, at the end of the last trading period, the closing price was at $197.54.

    According to Citigroup, the prior rating for Grupo Aeroportuario del Centro Norte SAB de CV (NASDAQ:OMAB) was changed from Neutral to Sell. In the third quarter, Central North Airport Gr showed an EPS of $1.13, compared to $0.81 from the year-ago quarter. The current stock performance of Central North Airport Gr shows a 52-week-high of $71.86 and a 52-week-low of $46.53. Moreover, at the end of the last trading period, the closing price was at $66.26.

    B of A Securities downgraded the previous rating for PENN Entertainment Inc (NASDAQ:PENN) from Buy to Neutral. In the third quarter, PENN Entertainment showed an EPS of $0.72, compared to $0.52 from the year-ago quarter. The stock has a 52-week-high of $53.36 and a 52-week-low of $25.49. At the end of the last trading period, PENN Entertainment closed at $35.04.

    For Stock Yards Bancorp Inc (NASDAQ:SYBT), Piper Sandler downgraded the previous rating of Neutral to Underweight. Stock Yards Bancorp earned $0.89 in the third quarter, compared to $0.87 in the year-ago quarter. The current stock performance of Stock Yards Bancorp shows a 52-week-high of $78.71 and a 52-week-low of $50.83. Moreover, at the end of the last trading period, the closing price was at $72.22.

    Barclays downgraded the previous rating for Skyline Champion Corp (NYSE:SKY) from Overweight to Equal-Weight. In the second quarter, Skyline Champion showed an EPS of $2.51, compared to $0.89 from the year-ago quarter. The current stock performance of Skyline Champion shows a 52-week-high of $83.49 and a 52-week-low of $43.04. Moreover, at the end of the last trading period, the closing price was at $55.72.

    Citigroup downgraded the previous rating for SL Green Realty Corp (NYSE:SLG) from Neutral to Sell. For the third quarter, SL Green Realty had an EPS of $1.66, compared to year-ago quarter EPS of $1.78. At the moment, the stock has a 52-week-high of $83.96 and a 52-week-low of $34.21. SL Green Realty closed at $36.35 at the end of the last trading period.

    For Coupa Software Inc (NASDAQ:COUP), Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Coupa Software had an EPS of $0.15, compared to year-ago quarter EPS of $0.31. The current stock performance of Coupa Software shows a 52-week-high of $166.21 and a 52-week-low of $40.30. Moreover, at the end of the last trading period, the closing price was at $78.60.

    For Caesars Entertainment Inc (NASDAQ:CZR), B of A Securities downgraded the previous rating of Buy to Neutral. In the third quarter, Caesars Entertainment showed an EPS of $0.24, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $97.39 and a 52-week-low of $31.31. At the end of the last trading period, Caesars Entertainment closed at $52.55.

    For Best Buy Co Inc (NYSE:BBY), B of A Securities downgraded the previous rating of Neutral to Underperform. Best Buy Co earned $1.38 in the third quarter, compared to $2.08 in the year-ago quarter. The current stock performance of Best Buy Co shows a 52-week-high of $112.96 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $84.07.

    B of A Securities downgraded the previous rating for AutoZone Inc (NYSE:AZO) from Neutral to Underperform. In the first quarter, AutoZone showed an EPS of $27.45, compared to $25.69 from the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of $2610.05 and a 52-week-low of $1703.32. Moreover, at the end of the last trading period, the closing price was at $2393.46.

    According to Daiwa Capital, the prior rating for XPeng Inc (NYSE:XPEV) was changed from Buy to Sell. XPeng earned $0.36 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.50 and a 52-week-low of $6.18. XPeng closed at $10.31 at the end of the last trading period.

    For Centerspace (NYSE:CSR), Janney Montgomery Scott downgraded the previous rating of Buy to Neutral. In the third quarter, Centerspace showed an EPS of $1.15, compared to $0.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $112.27 and a 52-week-low of $60.52. Centerspace closed at $66.15 at the end of the last trading period.

    Janney Montgomery Scott downgraded the previous rating for Essex Property Trust Inc (NYSE:ESS) from Buy to Neutral. In the third quarter, Essex Property Trust showed an EPS of $3.69, compared to $3.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $363.36 and a 52-week-low of $205.76. Essex Property Trust closed at $223.21 at the end of the last trading period.

    According to Truist Securities, the prior rating for Harpoon Therapeutics Inc (NASDAQ:HARP) was changed from Buy to Hold. In the third quarter, Harpoon Therapeutics showed an EPS of $0.35, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $8.20 and a 52-week-low of $0.66. At the end of the last trading period, Harpoon Therapeutics closed at $0.89.

    For Vornado Realty Trust (NYSE:VNO), Citigroup downgraded the previous rating of Neutral to Sell. Vornado Realty earned $0.81 in the third quarter, compared to $0.71 in the year-ago quarter. The stock has a 52-week-high of $47.26 and a 52-week-low of $20.03. At the end of the last trading period, Vornado Realty closed at $23.06.

    According to Citigroup, the prior rating for Acadia Realty Trust (NYSE:AKR) was changed from Buy to Neutral. Acadia Realty Trust earned $0.28 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.64 and a 52-week-low of $12.28. Acadia Realty Trust closed at $14.98 at the end of the last trading period.

    For Latham Group Inc (NASDAQ:SWIM), Barclays downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, Latham Group showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $27.25 and a 52-week-low of $2.75. At the end of the last trading period, Latham Group closed at $3.16.

    Morgan Stanley downgraded the previous rating for Martin Marietta Materials Inc (NYSE:MLM) from Overweight to Equal-Weight. For the third quarter, Martin Marietta Materials had an EPS of $4.69, compared to year-ago quarter EPS of $4.25. The stock has a 52-week-high of $446.46 and a 52-week-low of $284.99. At the end of the last trading period, Martin Marietta Materials closed at $368.73.

    For Adecoagro SA (NYSE:AGRO), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Adecoagro earned $0.43 in the third quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Adecoagro shows a 52-week-high of $13.55 and a 52-week-low of $6.78. Moreover, at the end of the last trading period, the closing price was at $7.62.

    For Syneos Health Inc (NASDAQ:SYNH), Mizuho downgraded the previous rating of Buy to Neutral. In the third quarter, Syneos Health showed an EPS of $1.23, compared to $1.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $104.17 and a 52-week-low of $22.89. Syneos Health closed at $35.50 at the end of the last trading period.

    Wells Fargo downgraded the previous rating for Digital Realty Trust Inc (NYSE:DLR) from Overweight to Equal-Weight. Digital Realty Trust earned $1.67 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Digital Realty Trust shows a 52-week-high of $178.22 and a 52-week-low of $85.76. Moreover, at the end of the last trading period, the closing price was at $111.09.

    According to Wells Fargo, the prior rating for Lear Corp (NYSE:LEA) was changed from Overweight to Equal-Weight. Lear earned $2.33 in the third quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Lear shows a 52-week-high of $195.43 and a 52-week-low of $114.67. Moreover, at the end of the last trading period, the closing price was at $132.19.

    For Magna International Inc (NYSE:MGA), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Magna International earned $1.07 in the third quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $90.15 and a 52-week-low of $45.58. Magna International closed at $59.87 at the end of the last trading period.

    Citigroup downgraded the previous rating for Marriott International Inc (NASDAQ:MAR) from Buy to Neutral. For the third quarter, Marriott Intl had an EPS of $1.69, compared to year-ago quarter EPS of $0.99. At the moment, the stock has a 52-week-high of $195.90 and a 52-week-low of $131.01. Marriott Intl closed at $163.12 at the end of the last trading period.

    According to Citigroup, the prior rating for Healthcare Realty Trust Inc (NYSE:HR) was changed from Buy to Neutral. In the third quarter, Healthcare Realty Trust showed an EPS of $0.39, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $32.38 and a 52-week-low of $18.40. At the end of the last trading period, Healthcare Realty Trust closed at $19.74.

    For Hilton Worldwide Holdings Inc (NYSE:HLT), Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Hilton Worldwide Holdings had an EPS of $1.31, compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $167.99 and a 52-week-low of $108.41. At the end of the last trading period, Hilton Worldwide Holdings closed at $138.11.

    For Easterly Government Properties Inc (NYSE:DEA), Citigroup downgraded the previous rating of Buy to Neutral. Easterly Government Props earned $0.32 in the third quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $23.65 and a 52-week-low of $14.79. At the end of the last trading period, Easterly Government Props closed at $15.04.

    For Brandywine Realty Trust (NYSE:BDN), Citigroup downgraded the previous rating of Neutral to Sell. Brandywine Realty Trust earned $0.36 in the third quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.88 and a 52-week-low of $5.95. Brandywine Realty Trust closed at $6.52 at the end of the last trading period.

    For Argo Blockchain PLC (NASDAQ:ARBK), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the second quarter, Argo Blockchain showed an EPS of $0.82, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $14.80 and a 52-week-low of $0.36. At the end of the last trading period, Argo Blockchain closed at $0.43.

    Goldman Sachs downgraded the previous rating for QuantumScape Corp (NYSE:QS) from Neutral to Sell. For the third quarter, QuantumScape had an EPS of $0.27, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $25.10 and a 52-week-low of $6.61. At the end of the last trading period, QuantumScape closed at $7.09.

    According to Baird, the prior rating for SPS Commerce Inc (NASDAQ:SPSC) was changed from Outperform to Neutral. For the third quarter, SPS Commerce had an EPS of $0.63, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $146.81 and a 52-week-low of $96.41. SPS Commerce closed at $137.97 at the end of the last trading period.

    For Certara Inc (NASDAQ:CERT), Baird downgraded the previous rating of Outperform to Neutral. Certara earned $0.10 in the third quarter, compared to $0.07 in the year-ago quarter. The stock has a 52-week-high of $29.99 and a 52-week-low of $10.60. At the end of the last trading period, Certara closed at $17.40.

    Jefferies downgraded the previous rating for Armstrong World Industries Inc (NYSE:AWI) from Buy to Hold. In the third quarter, Armstrong World Indus showed an EPS of $1.36, compared to $1.17 from the year-ago quarter. The stock has a 52-week-high of $117.64 and a 52-week-low of $70.50. At the end of the last trading period, Armstrong World Indus closed at $73.37.

    According to RBC Capital, the prior rating for Healthpeak Properties Inc (NYSE:PEAK) was changed from Outperform to Sector Perform. Healthpeak Properties earned $0.43 in the third quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $36.85 and a 52-week-low of $21.41. Healthpeak Properties closed at $25.63 at the end of the last trading period.

    According to Keybanc, the prior rating for VICI Properties Inc (NYSE:VICI) was changed from Overweight to Sector Weight. For the third quarter, VICI Properties had an EPS of $0.49, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $35.69 and a 52-week-low of $26.23. VICI Properties closed at $34.39 at the end of the last trading period.

    Keybanc downgraded the previous rating for Netstreit Corp (NYSE:NTST) from Overweight to Sector Weight. For the third quarter, Netstreit had an EPS of $0.30, compared to year-ago quarter EPS of $0.22. The stock has a 52-week-high of $23.86 and a 52-week-low of $17.07. At the end of the last trading period, Netstreit closed at $19.28.

    According to Keybanc, the prior rating for LTC Properties Inc (NYSE:LTC) was changed from Overweight to Sector Weight. LTC Properties earned $0.60 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $45.49 and a 52-week-low of $32.23. At the end of the last trading period, LTC Properties closed at $38.72.

    According to Keybanc, the prior rating for Essex Property Trust Inc (NYSE:ESS) was changed from Overweight to Sector Weight. In the third quarter, Essex Property Trust showed an EPS of $3.69, compared to $3.12 from the year-ago quarter. The current stock performance of Essex Property Trust shows a 52-week-high of $363.36 and a 52-week-low of $205.76. Moreover, at the end of the last trading period, the closing price was at $223.21.

    For Coupa Software Inc (NASDAQ:COUP), Keybanc downgraded the previous rating of Overweight to Sector Weight. For the third quarter, Coupa Software had an EPS of $0.15, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $166.21 and a 52-week-low of $40.30. Coupa Software closed at $78.60 at the end of the last trading period.

    According to Keybanc, the prior rating for Acadia Realty Trust (NYSE:AKR) was changed from Overweight to Sector Weight. Acadia Realty Trust earned $0.28 in the third quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $22.64 and a 52-week-low of $12.28. At the end of the last trading period, Acadia Realty Trust closed at $14.98.

    See all analyst ratings downgrades.

    Initiations

    UBS initiated coverage on Calumet Specialty Products Partners LP (NASDAQ:CLMT) with a Neutral rating. The price target for Calumet Specialty is set to $15.70. In the third quarter, Calumet Specialty showed an EPS of $0.19, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $20.50 and a 52-week-low of $8.40. At the end of the last trading period, Calumet Specialty closed at $14.02.

    UBS initiated coverage on Darling Ingredients Inc (NYSE:DAR) with a Buy rating. The price target for Darling Ingredients is set to $91.00. For the third quarter, Darling Ingredients had an EPS of $1.17, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $87.59 and a 52-week-low of $55.71. At the end of the last trading period, Darling Ingredients closed at $60.87.

    Cowen & Co. initiated coverage on The Simply Good Foods Co (NASDAQ:SMPL) with a Market Perform rating. The price target for Simply Good Foods is set to $42.00. In the fourth quarter, Simply Good Foods showed an EPS of $0.36, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $45.77 and a 52-week-low of $29.21. At the end of the last trading period, Simply Good Foods closed at $37.79.

    Deutsche Bank initiated coverage on Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) with a Buy rating. The price target for Maravai LifeSciences is set to $25.00. Maravai LifeSciences earned $0.37 in the third quarter, compared to $0.44 in the year-ago quarter. The current stock performance of Maravai LifeSciences shows a 52-week-high of $43.50 and a 52-week-low of $12.16. Moreover, at the end of the last trading period, the closing price was at $14.27.

    For Abcam PLC (NASDAQ:ABCM), Deutsche Bank initiated coverage, by setting the current rating at Hold. NoneAt the moment, the stock has a 52-week-high of $24.00 and a 52-week-low of $12.54. Abcam closed at $15.82 at the end of the last trading period.

    With a Buy rating, Canaccord Genuity initiated coverage on Olink Holding AB (NASDAQ:OLK). The price target seems to have been set at $28.00 for Olink Holding. In the third quarter, Olink Holding showed an EPS of $0.01, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $24.93 and a 52-week-low of $8.39. At the end of the last trading period, Olink Holding closed at $23.17.

    With an Outperform rating, Raymond James initiated coverage on POINT Biopharma Global Inc (NASDAQ:PNT). The price target seems to have been set at $10.00 for POINT Biopharma Global. In the third quarter, POINT Biopharma Global showed an EPS of $0.26, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $10.98 and a 52-week-low of $4.25. At the end of the last trading period, POINT Biopharma Global closed at $6.61.

    With a Buy rating, Needham initiated coverage on Revolution Medicines Inc (NASDAQ:RVMD). The price target seems to have been set at $31.00 for Revolution Medicines. In the third quarter, Revolution Medicines showed an EPS of $0.87, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $28.11 and a 52-week-low of $14.08. At the end of the last trading period, Revolution Medicines closed at $23.30.

    Cowen & Co. initiated coverage on BellRing Brands Inc (NYSE:BRBR) with an Outperform rating. The price target for BellRing Brands is set to $31.00. In the fourth quarter, BellRing Brands showed an EPS of $0.31, compared to $0.25 from the year-ago quarter. The current stock performance of BellRing Brands shows a 52-week-high of $28.95 and a 52-week-low of $20.20. Moreover, at the end of the last trading period, the closing price was at $25.12.

    Cowen & Co. initiated coverage on OneSpaWorld Holdings Ltd (NASDAQ:OSW) with an Outperform rating. The price target for OneSpaWorld Holdings is set to $13.00. In the third quarter, OneSpaWorld Holdings showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. The current stock performance of OneSpaWorld Holdings shows a 52-week-high of $10.99 and a 52-week-low of $6.80. Moreover, at the end of the last trading period, the closing price was at $10.30.

    Morgan Stanley initiated coverage on Broadridge Financial Solutions Inc (NYSE:BR) with a Equal-Weight rating. The price target for Broadridge Financial Soln is set to $160.00. In the first quarter, Broadridge Financial Soln showed an EPS of $0.84, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $185.40 and a 52-week-low of $131.35. Broadridge Financial Soln closed at $145.20 at the end of the last trading period.

    With a Buy rating, Needham initiated coverage on Day One Biopharmaceuticals Inc (NASDAQ:DAWN). The price target seems to have been set at $40.00 for Day One Biopharmaceutical. Day One Biopharmaceutical earned $0.53 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $28.35 and a 52-week-low of $5.44. At the end of the last trading period, Day One Biopharmaceutical closed at $20.10.

    Needham initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating. The price target for Theseus Pharmaceuticals is set to $22.00. In the third quarter, Theseus Pharmaceuticals showed an EPS of $0.38, compared to $5.16 from the year-ago quarter. The current stock performance of Theseus Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.01. Moreover, at the end of the last trading period, the closing price was at $5.50.

    Needham initiated coverage on Cogent Biosciences Inc (NASDAQ:COGT) with a Buy rating. The price target for Cogent Biosciences is set to $24.00. In the third quarter, Cogent Biosciences showed an EPS of $0.50, compared to $0.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.07 and a 52-week-low of $3.79. Cogent Biosciences closed at $11.95 at the end of the last trading period.

    Stifel initiated coverage on Aclaris Therapeutics Inc (NASDAQ:ACRS) with a Buy rating. The price target for Aclaris Therapeutics is set to $29.00. For the third quarter, Aclaris Therapeutics had an EPS of $0.30, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $18.96 and a 52-week-low of $9.26. At the end of the last trading period, Aclaris Therapeutics closed at $15.94.

    CLSA initiated coverage on Zhihu Inc (NYSE:ZH) with an Outperform rating. The price target for Zhihu is set to $1.50. For the third quarter, Zhihu had an EPS of $0.06, compared to year-ago quarter EPS of $0.07. The current stock performance of Zhihu shows a 52-week-high of $6.38 and a 52-week-low of $0.89. Moreover, at the end of the last trading period, the closing price was at $1.29.

    Goldman Sachs initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Sell rating. The price target for PTC Therapeutics is set to $35.00. In the third quarter, PTC Therapeutics showed an EPS of $1.53, compared to $1.89 from the year-ago quarter. The stock has a 52-week-high of $55.58 and a 52-week-low of $25.01. At the end of the last trading period, PTC Therapeutics closed at $40.14.

    Goldman Sachs initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ:XENE) with a Buy rating. The price target for Xenon Pharmaceuticals is set to $60.00. For the third quarter, Xenon Pharmaceuticals had an EPS of $0.57, compared to year-ago quarter EPS of $0.36. At the moment, the stock has a 52-week-high of $41.39 and a 52-week-low of $24.36. Xenon Pharmaceuticals closed at $38.07 at the end of the last trading period.

    With a Neutral rating, Citigroup initiated coverage on Solid Power Inc (NASDAQ:SLDP). The price target seems to have been set at $3.00 for Solid Power. In the third quarter, Solid Power showed an EPS of $0.07, compared to $0.08 from the year-ago quarter. The current stock performance of Solid Power shows a 52-week-high of $11.61 and a 52-week-low of $2.52. Moreover, at the end of the last trading period, the closing price was at $2.55.

    For RPM International Inc (NYSE:RPM), Keybanc initiated coverage, by setting the current rating at Sector Weight. RPM International earned $1.47 in the first quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $106.50 and a 52-week-low of $74.56. At the end of the last trading period, RPM International closed at $104.20.

    With a Buy rating, Needham initiated coverage on Blueprint Medicines Corp (NASDAQ:BPMC). The price target seems to have been set at $60.00 for Blueprint Medicines. Blueprint Medicines earned $2.23 in the third quarter, compared to $2.00 in the year-ago quarter. The current stock performance of Blueprint Medicines shows a 52-week-high of $111.78 and a 52-week-low of $40.78. Moreover, at the end of the last trading period, the closing price was at $46.60.

    For Mirati Therapeutics Inc (NASDAQ:MRTX), Needham initiated coverage, by setting the current rating at Hold. Mirati Therapeutics earned $3.09 in the third quarter, compared to $1.55 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $154.17 and a 52-week-low of $32.96. Moreover, at the end of the last trading period, the closing price was at $41.97.

    Canaccord Genuity initiated coverage on Pagaya Technologies Ltd (NASDAQ:PGY) with a Hold rating. The price target for Pagaya Technologies is set to $1.50. The stock has a 52-week-high of $34.50 and a 52-week-low of $0.63. At the end of the last trading period, Pagaya Technologies closed at $0.69.

    With a Buy rating, BTIG initiated coverage on CompoSecure Inc (NASDAQ:CMPO). The price target seems to have been set at $9.00 for CompoSecure. At the moment, the stock has a 52-week-high of $10.69 and a 52-week-low of $4.26. CompoSecure closed at $4.86 at the end of the last trading period.

    Deutsche Bank initiated coverage on Avantor Inc (NYSE:AVTR) with a Hold rating. The price target for Avantor is set to $24.00. Avantor earned $0.34 in the third quarter, compared to $0.35 in the year-ago quarter. The stock has a 52-week-high of $42.48 and a 52-week-low of $17.91. At the end of the last trading period, Avantor closed at $22.00.

    Deutsche Bank initiated coverage on Danaher Corp (NYSE:DHR) with a Buy rating. The price target for Danaher is set to $310.00. For the third quarter, Danaher had an EPS of $2.56, compared to year-ago quarter EPS of $2.39. The current stock performance of Danaher shows a 52-week-high of $331.23 and a 52-week-low of $233.71. Moreover, at the end of the last trading period, the closing price was at $276.68.

    Deutsche Bank initiated coverage on Repligen Corp (NASDAQ:RGEN) with a Hold rating. The price target for Repligen is set to $180.00. In the third quarter, Repligen showed an EPS of $0.77, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $274.09 and a 52-week-low of $137.21. Repligen closed at $177.99 at the end of the last trading period.

    With a Buy rating, Deutsche Bank initiated coverage on Bio-Techne Corp (NASDAQ:TECH). The price target seems to have been set at $100.00 for Bio-Techne. Bio-Techne earned $0.45 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $130.74 and a 52-week-low of $68.00. At the end of the last trading period, Bio-Techne closed at $86.98.

    With a Buy rating, Deutsche Bank initiated coverage on Thermo Fisher Scientific Inc (NYSE:TMO). The price target seems to have been set at $620.00 for Thermo Fisher Scientific. In the third quarter, Thermo Fisher Scientific showed an EPS of $5.08, compared to $5.77 from the year-ago quarter. The stock has a 52-week-high of $672.34 and a 52-week-low of $475.77. At the end of the last trading period, Thermo Fisher Scientific closed at $571.38.

    Deutsche Bank initiated coverage on 10x Genomics Inc (NASDAQ:TXG) with a Buy rating. The price target for 10x Genomics is set to $50.00. 10x Genomics earned $0.37 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $154.10 and a 52-week-low of $23.81. 10x Genomics closed at $35.21 at the end of the last trading period.

    With a Hold rating, Deutsche Bank initiated coverage on Waters Corp (NYSE:WAT). The price target seems to have been set at $350.00 for Waters. Waters earned $2.64 in the third quarter, compared to $2.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $375.24 and a 52-week-low of $265.61. Waters closed at $344.62 at the end of the last trading period.

    Deutsche Bank initiated coverage on West Pharmaceutical Services Inc (NYSE:WST) with a Hold rating. The price target for West Pharmaceutical Servs is set to $250.00. West Pharmaceutical Servs earned $2.03 in the third quarter, compared to $2.06 in the year-ago quarter. The stock has a 52-week-high of $475.00 and a 52-week-low of $206.19. At the end of the last trading period, West Pharmaceutical Servs closed at $251.90.

    Stifel initiated coverage on Pliant Therapeutics Inc (NASDAQ:PLRX) with a Buy rating. The price target for Pliant Therapeutics is set to $33.00. For the third quarter, Pliant Therapeutics had an EPS of $0.65, compared to year-ago quarter EPS of $0.75. The stock has a 52-week-high of $26.25 and a 52-week-low of $3.96. At the end of the last trading period, Pliant Therapeutics closed at $19.06.

    Stifel initiated coverage on Travere Therapeutics Inc (NASDAQ:TVTX) with a Hold rating. The price target for Travere Therapeutics is set to $22.00. For the third quarter, Travere Therapeutics had an EPS of $0.76, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $31.65 and a 52-week-low of $18.39. Travere Therapeutics closed at $18.93 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Clean Energy Fuels Corp (NASDAQ:CLNE). The price target seems to have been set at $12.00 for Clean Energy Fuels. For the third quarter, Clean Energy Fuels had an EPS of $0.06, compared to year-ago quarter EPS of $0.01. The current stock performance of Clean Energy Fuels shows a 52-week-high of $8.65 and a 52-week-low of $4.02. Moreover, at the end of the last trading period, the closing price was at $5.79.

    With a Buy rating, UBS initiated coverage on Plug Power Inc (NASDAQ:PLUG). The price target seems to have been set at $26.00 for Plug Power. In the third quarter, Plug Power showed an EPS of $0.30, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.62 and a 52-week-low of $12.70. Plug Power closed at $14.11 at the end of the last trading period.

    UBS initiated coverage on Bloom Energy Corp (NYSE:BE) with a Buy rating. The price target for Bloom Energy is set to $35.00. In the third quarter, Bloom Energy showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.47 and a 52-week-low of $11.47. Bloom Energy closed at $21.96 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Bunge Ltd (NYSE:BG). The price target seems to have been set at $133.00 for Bunge. For the third quarter, Bunge had an EPS of $3.45, compared to year-ago quarter EPS of $3.72. The stock has a 52-week-high of $128.40 and a 52-week-low of $80.41. At the end of the last trading period, Bunge closed at $94.47.

    With a Neutral rating, UBS initiated coverage on Gevo Inc (NASDAQ:GEVO). The price target seems to have been set at $2.25 for Gevo. For the third quarter, Gevo had an EPS of $0.19, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $5.49 and a 52-week-low of $1.73. Gevo closed at $2.00 at the end of the last trading period.

    UBS initiated coverage on FuelCell Energy Inc (NASDAQ:FCEL) with a Neutral rating. The price target for FuelCell Energy is set to $3.85. For the third quarter, FuelCell Energy had an EPS of $0.08, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $7.33 and a 52-week-low of $2.77. FuelCell Energy closed at $3.65 at the end of the last trading period.

    UBS initiated coverage on Vertex Energy Inc (NASDAQ:VTNR) with a Neutral rating. The price target for Vertex Energy is set to $6.90. In the third quarter, Vertex Energy showed an EPS of $0.28, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.10 and a 52-week-low of $3.30. Vertex Energy closed at $6.54 at the end of the last trading period.

    UBS initiated coverage on Montauk Renewables Inc (NASDAQ:MNTK) with a Sell rating. The price target for Montauk Renewables is set to $9.00. In the third quarter, Montauk Renewables showed an EPS of $0.08, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $20.78 and a 52-week-low of $9.10. At the end of the last trading period, Montauk Renewables closed at $12.01.

    UBS initiated coverage on Aemetis Inc (NASDAQ:AMTX) with a Neutral rating. The price target for Aemetis is set to $4.25. For the third quarter, Aemetis had an EPS of $0.46, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $16.97 and a 52-week-low of $3.71. At the end of the last trading period, Aemetis closed at $4.43.

    UBS initiated coverage on Green Plains Inc (NASDAQ:GPRE) with a Buy rating. The price target for Green Plains is set to $45.00. For the third quarter, Green Plains had an EPS of $1.27, compared to year-ago quarter EPS of $1.18. At the moment, the stock has a 52-week-high of $41.25 and a 52-week-low of $26.09. Green Plains closed at $31.25 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Archer-Daniels Midland Co (NYSE:ADM). The price target seems to have been set at $115.00 for Archer-Daniels Midland. In the third quarter, Archer-Daniels Midland showed an EPS of $1.86, compared to $0.97 from the year-ago quarter. The current stock performance of Archer-Daniels Midland shows a 52-week-high of $98.88 and a 52-week-low of $63.04. Moreover, at the end of the last trading period, the closing price was at $93.23.

    With a Buy rating, Needham initiated coverage on BellRing Brands Inc (NYSE:BRBR). The price target seems to have been set at $32.00 for BellRing Brands. BellRing Brands earned $0.31 in the fourth quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $28.95 and a 52-week-low of $20.20. At the end of the last trading period, BellRing Brands closed at $25.12.

    With a Buy rating, Needham initiated coverage on The Simply Good Foods Co (NASDAQ:SMPL). The price target seems to have been set at $42.00 for Simply Good Foods. In the fourth quarter, Simply Good Foods showed an EPS of $0.36, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.77 and a 52-week-low of $29.21. Simply Good Foods closed at $37.79 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ABCM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCM
    $ACRS
    $ADM
    $AGRO

    CompanyDatePrice TargetRatingAnalyst
    Certara Inc.
    $CERT
    2/27/2026$10.00Buy → Hold
    Craig Hallum
    Revolution Medicines Inc.
    $RVMD
    2/27/2026$145.00Buy
    UBS
    Essex Property Trust Inc.
    $ESS
    2/27/2026Outperform → Mkt Perform
    Raymond James
    Xenon Pharmaceuticals Inc.
    $XENE
    2/24/2026$60.00Outperform
    Wolfe Research
    Bloom Energy Corporation
    $BE
    2/24/2026$162.00Neutral
    Citigroup
    Lear Corporation
    $LEA
    2/19/2026$170.00Buy
    The Benchmark Company
    QuantumScape Corporation
    $QS
    2/19/2026$8.30Reduce → Hold
    HSBC Securities
    SolarEdge Technologies Inc.
    $SEDG
    2/19/2026$38.00 → $43.00Buy
    TD Cowen
    More analyst ratings

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tisch Daniel R bought $696,250 worth of shares (25,000 units at $27.85), increasing direct ownership by 500% to 30,000 units (SEC Form 4)

    4 - VORNADO REALTY TRUST (0000899689) (Issuer)

    2/26/26 4:30:06 PM ET
    $VNO
    Real Estate Investment Trusts
    Real Estate

    Director Lucier Gregory T bought $458,000 worth of shares (50,000 units at $9.16) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/23/26 8:53:53 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Summe Gregory L bought $940,000 worth of shares (100,000 units at $9.40) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/12/26 5:24:47 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Certara downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded Certara from Buy to Hold and set a new price target of $10.00

    2/27/26 8:32:38 AM ET
    $CERT
    Computer Software: Prepackaged Software
    Technology

    UBS resumed coverage on Revolution Medicines with a new price target

    UBS resumed coverage of Revolution Medicines with a rating of Buy and set a new price target of $145.00

    2/27/26 8:31:41 AM ET
    $RVMD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Essex Property downgraded by Raymond James

    Raymond James downgraded Essex Property from Outperform to Mkt Perform

    2/27/26 8:28:37 AM ET
    $ESS
    Real Estate Investment Trusts
    Real Estate

    $ABCM
    $ACRS
    $ADM
    $AGRO
    SEC Filings

    View All

    D/B/A Centerspace filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CENTERSPACE (0000798359) (Filer)

    2/27/26 4:15:29 PM ET
    $CSR
    Real Estate Investment Trusts
    Real Estate

    Healthcare Realty Trust Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Healthcare Realty Trust Inc (0001360604) (Filer)

    2/27/26 4:06:12 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 10-K filed by Calumet Inc.

    10-K - Calumet, Inc. /DE (0002013745) (Filer)

    2/27/26 4:02:59 PM ET
    $CLMT
    Integrated oil Companies
    Energy

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and COO Makagon Kira sold $780,279 worth of shares (22,196 units at $35.15), decreasing direct ownership by 6% to 339,545 units (SEC Form 4)

    4 - RingCentral, Inc. (0001384905) (Issuer)

    2/27/26 8:01:34 PM ET
    $RNG
    EDP Services
    Technology

    Chief Accounting Officer Arora Tarun sold $26,900 worth of shares (773 units at $34.80), decreasing direct ownership by 0.80% to 96,179 units (SEC Form 4)

    4 - RingCentral, Inc. (0001384905) (Issuer)

    2/27/26 8:00:47 PM ET
    $RNG
    EDP Services
    Technology

    Director Pinkus Gary S sold $207,250 worth of shares (1,250 units at $165.80), decreasing direct ownership by 23% to 4,149 units (SEC Form 4)

    4 - Bloom Energy Corp (0001664703) (Issuer)

    2/27/26 7:55:55 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    $ABCM
    $ACRS
    $ADM
    $AGRO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    April 30, 2024 - FDA Roundup: April 30, 2024

    For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/30/24 3:20:20 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 26, 2024 - FDA Roundup: April 26, 2024

    For Immediate Release: April 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/26/24 3:10:22 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Healthpeak Properties, Inc. Announces Public Filing of Registration Statement with the SEC for Janus Living, Inc.

    Healthpeak Properties, Inc. (NYSE:DOC) today announced that Janus Living, Inc., a pure-play senior housing real estate investment trust ("REIT"), has publicly filed a registration statement on Form S-11 with the Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of its shares of Class A-1 common stock. The offering is subject to market conditions, receipt of regulatory approvals, completion of related financings, completion of the SEC's review, and other customary conditions, and there can be no assurance as to whether or when the offering may be commenced or completed. The number of shares to be offered and the price range and other terms for the

    2/27/26 5:30:00 PM ET
    $DOC
    Real Estate Investment Trusts
    Real Estate

    Acadia Realty Trust Announces 2026 Annual Meeting Date

    Acadia Realty Trust (NYSE:AKR) ("Acadia" or the "Company") today announced the date of the Company's 2026 Annual Shareholder Meeting. Acadia's Board of Trustees has set the meeting date for Wednesday, May 13, 2026 at 1:00 PM, ET. As this will be conducted as a virtual meeting, shareholders will be able to attend, vote and submit questions via live webcast by visiting www.virtualshareholdermeeting.com/AKR26. Prior to the meeting, shareholders will be able to vote at www.proxyvote.com. About Acadia Realty Trust Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth. Acadia owns and operates a high-quality core real estate portfol

    2/27/26 4:15:00 PM ET
    $AKR
    Real Estate Investment Trusts
    Real Estate

    Essex Property Trust to Present at The 2026 Citigroup Global Property CEO Conference

    Essex Property Trust, Inc. (NYSE:ESS) announced today that Angela L. Kleiman, President and CEO, will be participating in a roundtable presentation at the 2026 Citigroup Global Property CEO Conference on Monday, March 2, 2026 at 2:55 p.m. Eastern Time. To listen to the panel, please visit the webcast link under the latest events section of the Company's Investors website at www.essex.com. An archive of the webcast will be available for thirty days following the event. A copy of any materials provided by the Company at the conference can be obtained through the Investors section of the Company's website. About Essex Property Trust, Inc. Essex Property Trust, Inc., an S&P 500 company, i

    2/27/26 4:15:00 PM ET
    $ESS
    Real Estate Investment Trusts
    Real Estate

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Leadership Updates

    Live Leadership Updates

    View All

    Broadridge Appoints Frank Troise as President, Global Capital Markets

    Proven innovator to lead front-to-back capital markets transformation across traditional and digital ecosystemsNEW YORK, Feb. 24, 2026 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) today announced the appointment of Frank Troise as President, Global Capital Markets, effective immediately. He will report to Tom Carey, President, Global Technology & Operations at Broadridge, and join Broadridge's Executive Leadership Team. A proven industry innovator, Troise steps into the role at a pivotal moment as issuance, trading, financing, data and post-trade services conve

    2/24/26 2:00:00 AM ET
    $BR
    Real Estate

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    PENN Entertainment Appoints Three New Independent Directors to Board

    Adds Heather Ace, Jeffrey Fox and Fabio Schiavolin, Bringing Decades of Experience in Global Gaming, Technology, Digital Infrastructure, Finance and Human Resources Enters into Cooperation Agreement with HG Vora PENN Entertainment, Inc. (NASDAQ:PENN) ("PENN" or the "Company") today announced the appointment of three new independent directors, Heather Ace, Jeffrey Fox and Fabio Schiavolin, to its Board of Directors (the "Board"), effective immediately. In connection with these appointments, the Company has entered into a cooperation agreement with HG Vora Capital Management, LLC and certain of its affiliates (collectively, "HG Vora"). David Handler, Chair of PENN's Board, said, "On beh

    2/23/26 7:00:00 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Financials

    Live finance-specific insights

    View All

    Calumet Reports Fourth Quarter and Fiscal Year 2025 Results

    Fiscal Year 2025 net loss of $33.8 million, or basic loss per common share of $0.39Fiscal Year 2025 Adjusted EBITDA with Tax Attributes of $293.3 million$222 million of recourse debt reduction in 2025Strong free cash flow driven by approximately $100 million of cost reduction initiatives in 2025Record production year in Specialty Products & Solutions segment and Montana RenewablesMontana Renewables MaxSAF®150 expansion on track for second quarter of 2026INDIANAPOLIS, Feb. 27, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us")  today reported its results for the fourth quarter and year ended December 31, 2025, as follows: Three Months Ended Decemb

    2/27/26 7:00:00 AM ET
    $CLMT
    Integrated oil Companies
    Energy

    Lennar Corporation to Broadcast Its First Quarter 2026 Earnings Call on March 13, 2026

    MIAMI, Feb. 26, 2026 /PRNewswire/ -- Lennar Corporation (NYSE:LEN), one of the nation's largest homebuilders, announced today that the Company will release its first quarter 2026 earnings after the market closes on March 12, 2026. Additionally, the Company will host a conference call on March 13, 2026 at 11:00 a.m. Eastern Time. The call will be broadcast live and can be accessed through Lennar's website at investors.lennar.com. If you are unable to participate during the live webcast, the call will be archived at investors.lennar.com for 90 days. Lennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-

    2/26/26 4:42:00 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Montauk Renewables Schedules Full Year 2025 Conference Call for Thursday, March 12, 2026, at 8:30 a.m. ET

    PITTSBURGH, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas ("RNG"), will host a conference call and webcast on Thursday, March 12, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the full year ended December 31, 2025. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the day prior to the conference call and webcast. Full Year 2025 Conference Call and Webcast Details  Date:Thursday, March 12, 2026Time:8:30 a.m. ETPartici

    2/26/26 4:30:00 PM ET
    $MNTK
    Natural Gas Distribution
    Utilities

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Healthcare Realty Trust Incorporated

    SC 13D/A - Healthcare Realty Trust Inc (0001360604) (Subject)

    12/9/24 7:38:49 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by CompoSecure Inc.

    SC 13D/A - CompoSecure, Inc. (0001823144) (Subject)

    11/29/24 5:29:17 PM ET
    $CMPO
    Finance: Consumer Services
    Finance